C12N 2760/12011
Bunyaviridae
C12N2760/12011 (Bunyaviridae) appears on 116 US grants and 141 published applications in this corpus.
Search patents in C12N- Granted patents
- 116
- Published applications
- 141
- Assignees
- 119
- Inventors
- 368
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 12 | 0 |
| 1999 | 6 | 0 |
| 2000 | 1 | 0 |
| 2001 | 5 | 0 |
| 2002 | 1 | 2 |
| 2003 | 6 | 4 |
| 2004 | 2 | 3 |
| 2005 | 0 | 1 |
| 2006 | 2 | 4 |
| 2007 | 0 | 1 |
| 2008 | 1 | 4 |
| 2009 | 0 | 4 |
| 2010 | 2 | 4 |
| 2011 | 1 | 10 |
| 2012 | 2 | 2 |
| 2013 | 0 | 8 |
| 2014 | 4 | 9 |
| 2015 | 5 | 6 |
| 2016 | 9 | 10 |
| 2017 | 9 | 3 |
| 2018 | 6 | 6 |
| 2019 | 5 | 3 |
| 2020 | 4 | 7 |
| 2021 | 3 | 12 |
| 2022 | 2 | 6 |
| 2023 | 7 | 10 |
| 2024 | 2 | 8 |
| 2025 | 5 | 10 |
| 2026 | 4 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2760/12022New viral proteins or individual genes, new structural or functional aspects ofIndexing code48
- C12N 2760/12211PhlebovirusIndexing code33
- C12N 2760/12111HantavirusIndexing code31
- C12N 2760/12034Use of virus or viral component as vaccineIndexing code26
- C12N 2760/12021Viruses as suchIndexing code7
- C12N 2760/12041Use of virus, viral particle or viral elements as a vectorIndexing code4
- C12N 2760/12051Methods of production or purification of viral materialIndexing code4
- C12N 2760/12061Methods of inactivation or attenuationIndexing code4
All 14 subgroupsShow fewer
- C12N 2760/12071Demonstrated in vivo effectIndexing code1
- C12N 2760/12023Virus like particles [vlp]Indexing code0
- C12N 2760/12031Uses of virus other than therapeutic or vaccineIndexing code0
- C12N 2760/12032Use of virus as therapeutic agent, other than vaccineIndexing code0
- C12N 2760/12033Use of viral protein as therapeutic agent other than vaccineIndexing code0
- C12N 2760/12088For redistributionIndexing code0
Recent patents
- Attenuated variant of the rift valley fever virus, composition comprising same, and uses thereof24 Mar 2026US 12,584,116 B2Consejo Superior De Investigaciones Cientificas (Csic)
- Crimean-Congo hemorrhagic fever virus M-segment nucleic acid vaccine and methods of use and production17 Mar 2026US 12,576,145 B2The Government of the United States, as represented by the Secretary of the Army
- Nucleic acid vaccine composition comprising a lipid formulation, and method of increasing the potency of nucleic acid vaccines27 Jan 2026US 12,533,410 B2Arcturus Therapeutics, Inc.
- Orthobunyavirus in human encephalitis and its diagnostic and therapeutic applications20 Jan 2026US 12,529,114 B2Assistance Publique-Hopitaux de Paris
- Systems and methods for the production of human polyclonal antibodies16 Dec 2025US 12,497,443 B2Sab, LLC
- Systems and methods for the production of human polyclonal antibodies11 Jun 2026US 2026/0159574 A1Sab, LLC
- Mutant of rsv f protein30 Apr 2026US 2026/0117202 A1National Vaccine and Serum Institute(Nvsi)
- Bunyavirales vaccine2 Apr 2026US 2026/0091101 A1CureVac AG
- Crimean-congo hemorrhagic fever virus replicon particles and use thereof15 Jan 2026US 2026/0014243 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Mrna vaccine for bandavirus dabieense and preparation method thereof6 Nov 2025US 2025/0339507 A1Nanjing Medical University
Most cited
By later US patents
- NYVAC vaccinia virus recombinants comprising heterologous inserts137US 5,494,807 AVirogenetics Corporation · 1996
- Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence128US 5,833,975 AVirogenetics Corporation · 1998
- Genetically engineered vaccine strain89US 5,364,773 AVirogenetics Corporation · 1994
- Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen89US 6,265,189 B1Virogenetics Corporation · 2001
- Antigen library immunization76US 6,541,011 B2Maxygen, Inc. · 2003